Report of Foreign Issuer (6-k)
April 11 2017 - 6:04AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of April, 2017
Commission File Number 1565025
AMBEV S.A.
(Exact name of registrant as specified in its charter)
AMBEV S.A.
(Translation of Registrant's name into English)
Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ___X___ Form 40-F _______
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes _______ No ___X____
CONSOLIDATED FORM
Management and Related Persons’ Transactions of Securities Issued by the Company
Article 11 - CVM Instruction # 358/2002
In March, 2017 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002
(1)
:
|
Company Name: Ambev S.A.
|
|
Group and Related Persons
|
( )
Board of Directors
|
( X )
Management
|
(
)
Fiscal Council
|
( )
Technical and Consulting Committees
|
Initial Balance
|
|
Securities / Derivatives
|
Securities Characteristics
(2)
|
Quantity
|
%
|
|
Same Class and Type
|
Total
|
|
Shares
|
Common
|
5,060,236
|
0.0322
|
0.0322
|
|
ADR (*)
|
Common
|
1,215,325
|
0.0077
|
0.0077
|
Transac
tions in the month
|
|
Securities / Derivatives
|
Securities Characteristics
(2)
|
Intermediary
|
Operation
|
Day
|
Quantity
|
Price
|
Volume (R$)
(3)
|
|
Shares
|
Common
|
N/A
|
Donation (In)
|
03
|
5,000
|
0.00
|
0.00
|
|
Shares
|
Common
|
Direct with the Company
|
Subs Deferred Shares
|
22
|
52,615
|
2.13109
|
112,127.29
|
|
Shares
|
Common
|
Direct with the Company
|
Subs Deferred Shares
|
22
|
24,039
|
2.13077
|
51,221.55
|
|
Shares
|
Common
|
Direct with the Company
|
Subs Deferred Shares
|
22
|
9,471
|
4.87584
|
46,179.14
|
|
Shares
|
Common
|
Direct with the Company
|
Subs Deferred Shares
|
22
|
7,542
|
4.85407
|
36,609.44
|
|
Shares
|
Common
|
Direct with the Company
|
Subs Deferred Shares
|
22
|
7,159
|
2.15791
|
15,448.52
|
|
Shares
|
Common
|
Direct with the Company
|
Subs Deferred Shares
|
22
|
9,849
|
4.87196
|
47,983.95
|
|
|
|
|
Total Buy
|
|
115,675
|
|
309,569.89
|
|
|
|
|
|
|
|
|
|
|
Shares
|
Common
|
Ágora Corretora
|
Sell
|
02
|
500
|
17.21
|
8,605.00
|
|
Shares
|
Common
|
Ágora Corretora
|
Sell
|
03
|
600
|
17.15
|
10,290.00
|
|
Shares
|
Common
|
Ágora Corretora
|
Sell
|
03
|
1,100
|
17.16
|
18,876.00
|
|
Shares
|
Common
|
N/A
|
Donation (Out)
|
03
|
5,000
|
0.00
|
0.00
|
|
Shares
|
Common
|
Itaú Corretora
|
Sell
|
06
|
1,100
|
17.29
|
19,019.00
|
|
Shares
|
Common
|
Itaú Corretora
|
Sell
|
09
|
5,800
|
17.33
|
100,514.00
|
|
Shares
|
Common
|
Ágora Corretora
|
Sell
|
10
|
1,000
|
17.36
|
17,360.00
|
|
Shares
|
Common
|
Ágora Corretora
|
Sell
|
17
|
1,000
|
17.41
|
17,410.00
|
|
Shares
|
Common
|
Ágora Corretora
|
Sell
|
20
|
1,000
|
17.54
|
17,540.00
|
|
Shares
|
Common
|
JP Morgan
|
Sell
|
21
|
209,800
|
17.45
|
3,661,010.00
|
|
Shares
|
Common
|
JP Morgan
|
Sell
|
21
|
6,400
|
17.46
|
111,744.00
|
|
Shares
|
Common
|
JP Morgan
|
Sell
|
21
|
23,200
|
17.48
|
405,536.00
|
|
Shares
|
Common
|
JP Morgan
|
Sell
|
21
|
600
|
17.49
|
10,494.00
|
|
Shares
|
Common
|
Ágora Corretora
|
Sell
|
22
|
500
|
17.30
|
8,650.00
|
|
Shares
|
Common
|
Ágora Corretora
|
Sell
|
28
|
1,000
|
17.90
|
17,900.00
|
|
Shares
|
Common
|
Ágora Corretora
|
Sell
|
29
|
2,000
|
18.12
|
36,240.00
|
|
Shares
|
Common
|
Ágora Corretora
|
Sell
|
30
|
10,000
|
18.20
|
182,000.00
|
|
|
|
|
Total Sell
|
|
270,600
|
|
4,643,188.00
|
Final Balance
|
|
Securities / Derivatives
|
Securities Characteristics
(2)
|
Quantity
|
%
|
|
Same Class and Type
|
Total
|
|
Shares
|
Common
|
4,905,311
|
0.0312
|
0.0312
|
|
ADR (*)
|
Common
|
1,215,325
|
0.0077
|
0.0077
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
When filling in the form, delete the lines that do not have any information. If
there is no acquisition/change in the position of any person in relation to Article
11 - CVM Instruction # 358/2002, send a statement with that information.
(2) Issue/Series,
convertibility, simple, term, guaranties, type/class, among others.
(3) Quantity multiplied
by price.
Note: These consolidated data must
have information by group: Directors, Management (which have not been included
in the Board of Directors), etc.
(*) Each ADR is equivalent to 1 (one)
share.
Note: The inicial balance was increased by 20,225
ADRs when compared to the final balance of the previous month (february/2017),
as the Company was informed by an executive officer that his participation in
ADRs required rectification.
CONSOLIDATED FORM
Management and Related Persons’ Transactions of Securities Issued by the Company
Article 11 - CVM Instruction # 358/2002
In March, 2017 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002
(1)
:
|
Company Name: Ambev S.A.
|
|
Group and Related Persons
|
( X )
Board of Directors
|
( )
Management
|
(
)
Fiscal Council
|
( )
Technical and Consulting Committees
|
Initial Balance
|
|
Securities / Derivatives
|
Securities Characteristics
(2)
|
Quantity
|
%
|
|
Same Class and Type
|
Total
|
|
Shares
|
Common
|
26,529,315
|
0.1688
|
0.1688
|
|
ADR (*)
|
Common
|
619,333
|
0.0039
|
0.0039
|
Transac
tions in the month
|
|
Securities / Derivatives
|
Securities Characteristics
(2)
|
Intermediary
|
Operation
|
Day
|
Quantity
|
Price
|
Volume
(3)
|
|
Shares
|
Common
|
Direct with the Company
|
Subs Deferred Shares
|
22
|
190,937
|
R$ 4.08647
|
R$ 780,258.19
|
|
|
|
|
Total Buy
|
|
190,937
|
|
R$ 780,258.19
|
|
ADR (*)
|
Common
|
Direct with the Company
|
Subs Deferred ADRs
|
22
|
103,698
|
US 0.64916
|
US 67,317.44
|
|
|
|
|
Total Sell
|
|
103,698
|
|
US 67,317.44
|
Final Balance
|
|
Securities / Derivatives
|
Securities Characteristics
(2)
|
Quantity
|
%
|
|
Same Class and Type
|
Total
|
|
Shares
|
Common
|
26,720,252
|
0.1700
|
0.1700
|
|
ADR (*)
|
Common
|
723,031
|
0.0046
|
0.0046
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.
(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.
(3) Quantity multiplied by price.
Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.
(*) Each ADR is equivalent to 1 (one) share.
CONSOLIDATED FORM
Management and Related Persons’ Transactions of Securities Issued by the Company
Article 11 - CVM Instruction # 358/2002
In March, 2017 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002
(1)
:
|
Company Name: Ambev S.A.
|
|
Group and related persons
|
( ) Board of Directors
|
( ) Management
|
(X) Fiscal Council
|
( ) Technical and Consulting Committees
|
Initial Balance
|
|
Securities / Derivatives
|
Securities Characteristics
(2)
|
Quantity
|
%
|
|
Same Class and Type
|
Total
|
|
Shares
|
Common
|
7,225
|
0.0000
|
0.0000
|
Final Balance
|
|
Securities / Derivatives
|
Securities Characteristics
(2)
|
Quantity
|
%
|
|
Same Class and Type
|
Tot
al
|
|
Shares
|
Common
|
7,225
|
0.0000
|
0.0000
|
|
|
|
|
|
|
|
|
|
(1)
When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.
(2)
Issue/Series, convertibility, simple, term, guaranties, type/class, among others.
(3)
Quantity multiplied by price.
Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: April 10, 2017
|
|
|
|
|
|
AMBEV S.A.
|
|
|
|
|
|
|
By:
|
/s/
Ricardo Rittes de Oliveira Silva
|
|
|
Ricardo Rittes de Oliveira Silva
Chief Financial and Investor Relations Officer
|
Ambev (NYSE:ABEV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ambev (NYSE:ABEV)
Historical Stock Chart
From Sep 2023 to Sep 2024
